Efforts to make and apply humanized yeast

Briefings in Functional Genomics

Volumn 15, Issue 2, 2016, Pages 155-163

  Laurent, Jon M ^a   Young, Jonathan H ^b   Kachroo, Aashiq H ^a   Marcotte, Edward M ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b Institute for Cellular and Molecular Biology at the University of Texas at Austin ^*

Author keywords

Evolution; Functional genomics; High throughput assays; Humanization; Yeast

Indexed keywords

AMINO ACID; PROTEIN;

ARTICLE; BIOLOGY; EVOLUTION; FUNGAL GENE; GENETIC CONSERVATION; GENETIC MANIPULATION; HUMAN; NONHUMAN; ORTHOLOGY; PROTEIN EXPRESSION; SACCHAROMYCES CEREVISIAE; BIOLOGICAL MODEL; DISEASES; DRUG DEVELOPMENT; DRUG EFFECTS; GENETICS; GENOMICS; METABOLISM;

DISEASE; DRUG DISCOVERY; GENES, FUNGAL; GENOMICS; HUMANS; MODELS, BIOLOGICAL; PROTEINS; SACCHAROMYCES CEREVISIAE;

EID: 84964873019     PISSN: 20412649     EISSN: 20412657     Source Type: Journal    
DOI: 10.1093/bfgp/elv041     Document Type: Article

References (69)

1. Douzery EJP, Snell EA, Bapteste E, et al. The timing of eukaryotic evolution: does a relaxed molecular clock reconcile proteins and fossils? Proc Natl Acad Sci USA. 2004;101 (43):15386-91.
2. Remm M, Storm CEV, Sonnhammer ELL. Automatic clustering of orthologs and in-paralogs from pairwise species comparisons. J Mol Biol 2001;314(5):1041-52.
3. Giaever G, Chu AM, Ni L, et al. Functional profiling of the Saccharomyces cerevisiae genome. Nature 2002;418(6896): 387-91.
4. Kataoka T, Powers S, Cameron S, et al. Functional homology of mammalian and yeast RAS genes. Cell 1985; 40(1):19-26.
5. Lee MG, Nurse P. Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2. Nature 1987;327(6117):31-5.
6. Kachroo AH, Laurent JM, Yellman CM, et al. Systematic humanization of yeast genes reveals conserved functions and genetic modularity. Science. 2015;348(6237):921-5.
7. Heinicke S, Livstone MS, Lu C, et al. The Princeton Protein Orthology Database (P-POD): a comparative genomics analysis tool for biologists. PLoS One 2007;2(8):e766.
8. Cherry JM, Hong EL, Amundsen C, et al. Saccharomyces Genome Database: the genomics resource of budding yeast. Nucleic Acids Res 2012;40(Database issue):D700-5.Oxford University Press.
9. Dunham MJ, Fowler DM. Contemporary, yeast-based approaches to understanding human genetic variation. Curr Opin Genet Dev 2013;23(6):658-64.
10. Nasmyth KA, Reed SI. Isolation of genes by complementation in yeast: molecular cloning of a cell-cycle gene. Proc Natl Acad Sci USA 1980;77(4):2119-23.
11. Williamson DH. The timing of deoxyribonucleic acid synthesis in the cell cycle of Saccharomyces cerevisiae. J Cell Biol 1965;25(3):517-28.The Rockefeller University Press.
12. Stossel TP. The discovery of statins. Cell 2008;134(6):903-5.
13. McGary KL, Park TJ, Woods JO, et al. Systematic discovery of nonobvious human disease models through orthologous phenotypes. Proc Natl Acad Sci USA 2010;107(14):6544-9.
14. Cha HJ, Byrom M, Mead PE, et al. Evolutionarily repurposed networks reveal the well-known antifungal drug thiabendazole to be a novel vascular disrupting agent. PLoS Biol 2012;10(8):e1001379.
15. Hillenmeyer ME, Fung E, Wildenhain J, et al. The chemical genomic portrait of yeast: uncovering a phenotype for all genes. Science 2008;320(5874):362-5.
16. Steinmetz LM, Scharfe C, Deutschbauer AM, et al. Systematic screen for human disease genes in yeast. Nat Genet 2002; 31(4):400-4.
17. Luesch H, Wu TYH, Ren P, et al. A genome-wide overexpression screen in yeast for small-molecule target identification. Chem Biol 2005;12(1):55-63.
18. Lum PY, Armour CD, Stepaniants SB, et al. Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. Cell 2004;116(1):121-37.
19. Costanzo M, Alizadeh S, Baryshnikova A, et al. The genetic landscape of a cell. Science 2010;327(5964):425-31.
20. Parsons AB, Brost RL, Ding H, et al. Integration of chemicalgenetic and genetic interaction data links bioactive compounds to cellular target pathways. Nat Biotechnol 2004;22(1):62-9.
21. Parsons AB, Lopez A, Givoni IE, et al. Exploring the mode-ofaction of bioactive compounds by chemical-genetic profiling in yeast. Cell 2006;126(3):611-25.
22. Tamble CM, St Onge RP, Giaever G, et al. The synthetic genetic interaction network reveals small molecules that target specific pathways in Sacchromyces cerevisiae. Mol BioSyst 2011; 7(6):2019-30.
23. Bian Y, Kitagawa R, Bansal PK, et al. Synthetic genetic array screen identifies PP2A as a therapeutic target in Mad2-overexpressing tumors. Proc Natl Acad Sci USA 2014;111(4): 1628-33.
24. Ho C-H, Magtanong L, Barker SL, et al. A molecular barcoded yeast ORF library enables mode-of-action analysis of bioactive compounds. Nat Biotechnol 2009;27(4):369-77.
25. Sekigawa M, Kunoh T, Wada S-I, et al. Comprehensive screening of human genes with inhibitory effects on yeast growth and validation of a yeast cell-based system for screening chemicals. J Biomol Screen 2010;15(4):368-78.
26. Telli ML. PARP inhibitors in cancer: moving beyond BRCA. Lancet Oncol 2011;12(9):827-8.
27. Perkins E, Sun D, Nguyen A, et al. Novel inhibitors of poly(ADP-ribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast. Cancer Res 2001; 61(10):4175-83.
28. Couthouis J, Hart MP, Shorter J, et al. A yeast functional screen predicts new candidate ALS disease genes. Proc Natl Acad Sci USA 2011;108(52):20881-90.
29. Tardiff DF, Tucci ML, Caldwell KA, et al. J Biol Chem 2012;287(6):4107-20.
30. Tardiff DF, Jui NT, Khurana V, et al. Yeast reveal a "druggable" Rsp5/Nedd4 network that ameliorates α-synuclein toxicity in neurons. Science 2013;342(6161):979-83.
31. Mayfield JA, Davies MW, Dimster-Denk D, et al. Surrogate genetics and metabolic profiling for characterization of human disease alleles. Genetics 2012;190(4):1309-23.
32. Chung CY, Khurana V, Auluck PK, et al. Identification and rescue of α-synuclein toxicity in Parkinson patient-derived neurons. Science 2013;342(6161):983-7.
33. Treusch S, Hamamichi S, Goodman JL, et al. Functional links between Aβ toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeast. Science 2011;334 (6060):1241-5.
34. Miller MP, Kumar S. Understanding human disease mutations through the use of interspecific genetic variation. Hum Mol Genet 2001;10(21):2319-28.
35. Lasserre J-P, Dautant A, Aiyar RS, et al. Yeast as a system for modeling mitochondrial disease mechanisms and discovering therapies. Dis Model Mech 2015;8(6):509-26.
36. Stumpf JD, Copeland WC. Mitochondrial DNA replication and disease: insights from DNA polymerase γ mutations. Cell Mol Life Sci 2010;68(2):219-33. SP Birkhäuser Verlag Basel.
37. Stuart GR, Santos JH, Strand MK, et al. Mitochondrial and nuclear DNA defects in Saccharomyces cerevisiae with mutations in DNA polymerase gamma associated with progressive external ophthalmoplegia. Hum Mol Genet 2006;15(2):363-74.
38. Baruffini E, Lodi T, Dallabona C, et al. Genetic and chemical rescue of the Saccharomyces cerevisiae phenotype induced by mitochondrial DNA polymerase mutations associated with progressive external ophthalmoplegia in humans. Hum Mol Genet 2006;15(19):2846-55. Oxford University Press.
39. Ghezzi D, Baruffini E, Haack TB, et al. Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis. Am J Hum Genet 2012;90(6):1079-87. Elsevier.
40. Gammie AE, Erdeniz N, Beaver J, et al. Functional characterization of pathogenic human MSH2 missense mutations in Saccharomyces cerevisiae. Genetics 2007;177(2):707-21.
41. Melamed D, Young DL, Miller CR, et al. Combining natural sequence variation with high throughput mutational data to reveal protein interaction sites. PLoS Genet 2015;11(2): e1004918.
42. De Keersmaecker K, Atak ZK, Li N, et al. Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia. Nat Genet 2013;45(2):186-90.
43. Sulima SO, Patchett S, Advani VM, et al. Bypass of the pre-60S ribosomal quality control as a pathway to oncogenesis. Proc Natl Acad Sci USA 2014;111(15):5640-5.
44. Jordan DM, Frangakis SG, Golzio C, et al. Identification of cissuppression of human disease mutations by comparative genomics. Nature 2015;524(7564):225-9.
45. Marini NJ, Thomas PD, Rine J. The use of orthologous sequences to predict the impact of amino acid substitutions on protein function. PLoS Genet 2010;6(5):e1000968.
46. Marini NJ, Gin J, Ziegle J, et al. The prevalence of folateremedial MTHFR enzyme variants in humans. Proc Natl Acad Sci USA 2008;105(23):8055-60.
47. Kruger WD, Cox DR. A yeast system for expression of human cystathionine beta-synthase: structural and functional conservation of the human and yeast genes. Proc Natl Acad Sci USA 1994;91(14):6614-8.
48. Harley CB. Telomerase and cancer therapeutics. Nature Reviews Cancer 2008;8(3):167-79.
49. Henning KA, Moskowitz N, Ashlock MA, et al. Humanizing the yeast telomerase template. Proc Natl Acad Sci USA 1998;95(10):5667-71.
50. Bah A, Bachand F, Clair E, et al. Humanized telomeres and an attempt to express a functional human telomerase in yeast. Nucleic Acids Res 2004;32(6):1917-27.
51. Wong LH, Unciti-Broceta A, Spitzer M, et al. A yeast chemical genetic screen identifies inhibitors of human telomerase. Chem Biol 2013;20(3):333-40.
52. Qian Y, Kachroo AH, Yellman CM, et al. Yeast cells expressing the human mitochondrial DNA polymerase reveal correlations between polymerase fidelity and human disease progression. J Biol Chem 2014;289(9):5970-85.
53. Qian Y, Ziehr JL, Johnson KA. Alpers disease mutations in human DNA polymerase gamma cause catalytic defects in mitochondrial DNA replication by distinct mechanisms. Front Genet 2015;6:135.
54. Zhang N, Osborn M, Gitsham P, et al. Using yeast to place human genes in functional categories. Gene 2003;303:121-9.
55. Wildt S, Gerngross TU. The humanization of Nglycosylation pathways in yeast. Nat Rev Microbiol 2005; 3(2):119-28.
56. Choi B-K, Bobrowicz P, Davidson RC, et al. Use of combinatorial genetic libraries to humanize N-linked glycosylation in the yeast Pichia pastoris. Proc Natl Acad Sci USA 2003;100(9):5022-7.
57. Hamilton SR, Bobrowicz P, Bobrowicz B, et al. Production of complex human glycoproteins in yeast. Science 2003;301(5637):1244-6.
58. Hamilton SR, Davidson RC, Sethuraman N, et al. Humanization of yeast to produce complex terminally sialylated glycoproteins. Science 2006;313(5792):1441-3.
59. Labunskyy VM, Suzuki Y, Hanly TJ, et al. The insertion Green Monster (iGM) method for expression of multiple exogenous genes in yeast. G3 (Bethesda) 2014;4(7):1183-91.
60. Davey MJ, Andrighetti HJ, Ma X, et al. A synthetic human kinase can control cell cycle progression in budding yeast. G3 (Bethesda) 2011;1(4):317-25.
61. Gao X-D, Tachikawa H, Sato T, et al. Alg14 recruits Alg13 to the cytoplasmic face of the endoplasmic reticulum to form a novel bipartite UDP-N-acetylglucosamine transferase required for the second step of N-linked glycosylation. J Biol Chem 2005;280(43):36254-62.
62. Ozanick S, Krecic A, Andersland J, et al. The bipartite structure of the tRNA m1A58 methyltransferase from S. cerevisiae is conserved in humans. RNA 2005;11(8):1281-90.
63. Lamesch P, Li N, Milstein S, et al. hORFeome v3.1: a resource of human open reading frames representing over 10,000 human genes. Genomics 2007;89(3):307-15.
64. Pan X, Yuan DS, Xiang D, et al. A robust toolkit for functional profiling of the yeast genome. Mol Cell 2004; 16(3):487-96.
65. Sopko R, Huang D, Preston N, et al. Mapping pathways and phenotypes by systematic gene overexpression. Mol Cell 2006;21(3):319-30.
66. Annaluru N, Muller H, Mitchell LA, et al. Total synthesis of a functional designer eukaryotic chromosome. Science 2014;344(6179):55-8.
67. DiCarlo JE, Norville JE, Mali P, et al. Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems. Nucleic Acids Res 2013;41(7):4336-43. Oxford University Press.
68. Suzuki Y, Onge RPS, Mani R, et al. Knocking out multigene redundancies via cycles of sexual assortment and fluorescence selection. Nat Methods 2011;8(2):159-64. Nature Publishing Group.
69. Fowler DM, Stephany JJ, Fields S. Measuring the activity of protein variants on a large scale using deep mutational scanning. Nat Protoc 2014;9(9):2267-84.